Retraction: The nexus between VEGF and NFκB orchestrates a hypoxia-independent neovasculogenesis (PLoS ONE (2013) 8: 3 (e59021) DOI: 10.1371/journal.pone.0059021);The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  DeNiro, Michael ^a,b,e   Al Mohanna, Falah H ^b   Alsmadi, Osama ^c   Al Mohanna, Futwan A ^b,d  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c DASMAN DIABETES INSTITUTE   (Kuwait)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA1 PROTEIN; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; GELATINASE B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIFICIGUAT; PROTEIN EPO; PROTEIN ET 1; PROTEIN FAK; STROMAL CELL DERIVED FACTOR 1; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIC CELL; LINKAGE ANALYSIS; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR MODEL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

EID: 84875356107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0227432     Document Type: Erratum

References (27)

1. Stein I, Neeman M, Shweiki D, Itin A, Keshet E, (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 10: 5363-8.
2. Campochiaro P (2010) Molecular Targets for Retinal Diseases: Hypoxia-regulated genes play an important role in vascular permeability and neovascularization. Retina Today July/August Supplement: 4-7.
3. DeNiro M, Alsmadi O, Al-Mohanna F, (2009) Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. Exp Eye Res 89: 700-17.
4. DeNiro M, Al-Halafi A, Al-Mohanna FH, Alsmadi O, Al-Mohanna FA, (2010) Pleiotropic Effects of YC-1 Selectively Inhibits Pathological Retinal Neovascularization and Promotes Physiological Revascularization in a Mouse Model of Oxygen-Induced Retinopathy. Mol Pharmacol 77: 348-67.
5. Keunen JE, Hooymans JM, Ulbig MW, Shields CL, (2002) Retinal neovascularization in choroidal melanoma without retinal ischemia. Retina 3: 371-4.
6. Hayreh SS, Zimmerman MB, (2012) Ocular neovascularization associated with central and hemicentral retinal vein occlusion. Retina 8: 1553-65.
7. Balamurugan AN, Gu Y, Miyamoto M, Wang W, Inoue K, et al. (2003) Streptozotocin (STZ) is commonly used to induce diabetes in animal models. Pancreas 26: 102-103.
8. Kowluru RA, (2002) Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 24: 123-128.
9. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, et al. (2002) Nonsteroidal anti-inflammatory drugs prevent early DR via TNF-alpha suppression. FASEB J 16: 438-440.
10. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, et al. (1994) Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35: 981-990.
11. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, et al. (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells: Penn State Retina Research Group. Diabetes 47: 1953-1959.
12. Wright WS, McElhatten RM, Harris NR, (2011) Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat. Exp Eye Res 4: 437-41.
13. Karin M, Cao Y, Greten FR, Li ZW, (2002) NFκB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
14. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620.
15. Marumo T, Schini-Kerth VB, Busse R, (1999) Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48: 1131-1137.
16. Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, et al. (2001) Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Cancer Res 5: 2015-21.
17. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM, (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84: 4226-4233.
18. Chang MS, Lee WS, Chen BC, Sheu JR, Lin CH, (2004) YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells. Mol Pharmacol 3: 561-71.
19. Pilz RB, Broderick KE, (2005) Role of cyclic GMP in gene regulation Front Biosci. 10: 1239-68.
20. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, et al. (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative DR. Invest Ophthalmol Vis Sci 38: 36-47.
21. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, et al. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 23: 10457-61.
22. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, et al. (1997) Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99: 2192-2202.
23. Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, et al. (2003) VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci 4: 665-74.
24. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, et al. (2004) NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 17: 7806-19.
25. Huang YT, Pan SL, Guh JH, Chang YL, Lee FY, et al. (2005) YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells. Mol Cancer Ther 10: 1628-35.
26. DeNiro M, Al-Mohanna FH, Al-Mohanna FA, (2011) Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy. PLoS ONE 6: e22244.
27. DeNiro M, Al-Mohanna FA, (2012) Zinc Transporter 8 [ZnT8] Expression is Reduced by Ischemic Insults: A Potential Therapeutic Target to Prevent Ischemic Retinopathy. PLoS One 11: e50360.